Invesaro

Stocks ULBI DCF valuation

DCF valuation

What is Ultralife Corp worth?

With the base-case assumptions below, a discounted cash flow model on Ultralife Corp's reported free cash flow gives $9.10 per share. The share price was $15.79 on November 10, 2026, 73% above that value.

Inputs from the filings

Free cash flow, fiscal 2025
$7.1M
Average free cash flow, last 5 years
$4M
Cash
$7.6M
balance sheet of September 30, 2026
Debt
$50.5M
balance sheet of September 30, 2026
Diluted shares, fiscal 2025
16,642,000
Revenue growth per year, last 5 years
12.2%

Three sets of assumptions

CaseGrowth yrs 1-5Growth yrs 6-10After year 10Discount rateValue per shareValue vs price
Bear7.0%4.5%2.0%10.0%$4.67-70%
Base12.0%7.0%2.5%9.0%$9.10-42%
Bull17.0%10.0%3.0%8.0%$17.94+14%

Sensitivity: base case value per share

Discount rate down the side, growth after year 10 across the top. Everything else as in the base case.

1.5%2.0%2.5%3.0%3.5%
7.0%$12.49$13.53$14.81$16.41$18.46
8.0%$9.95$10.63$11.43$12.39$13.57
9.0%$8.11$8.57$9.10$9.73$10.47
10.0%$6.70$7.03$7.41$7.83$8.33
11.0%$5.60$5.85$6.12$6.42$6.76

Where the presets come from

Base: years 1 to 5 grow at Ultralife Corp's revenue growth rate over the last 5 fiscal years (12.2% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.

Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.

Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.

This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.

Adjust the assumptions

Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.

Adjust the assumptions

Ultralife Corp company page